Most (27/28, 96.4%) NIID patients exhibited varying degrees of cognitive decline (MMSE < 27 and/or MoCA < 26), and as many as two-thirds (19/28, 67.8%) fulfilled the diagnostic criteria for dementia (MMSE ≤ 24). This evidence concerns the gene DOCK3 and neuronal intranuclear inclusion disease.